Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
15.10
+0.55 (3.78%)
May 18, 2026, 4:00 PM EDT - Market closed
Caris Life Sciences Market Cap
Caris Life Sciences has a market cap or net worth of $4.27 billion as of May 19, 2026.
Market Cap
4.27B
Enterprise Value
3.88B
1-Year Change
n/a
Ranking
Category
Stock Price
$15.10
Market Cap Chart
Since the IPO on June 18, 2025, Caris Life Sciences's market cap has decreased from $5.95B to $4.27B, a decrease of -28.32%. That is a compound annual growth rate of -30.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 4.27B | -43.93% |
| Dec 31, 2025 | 7.61B | 27.84% |
| Jun 18, 2025 | 5.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Legend Biotech | 5.01B |
| CRISPR Therapeutics AG | 4.68B |
| Dianthus Therapeutics | 4.57B |
| Ligand Pharmaceuticals | 4.17B |
| Veradermics | 4.13B |
| Travere Therapeutics | 3.99B |
| NewAmsterdam Pharma Company | 3.93B |
| Catalyst Pharmaceuticals | 3.82B |